Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer-Reference-Cited by-同舟云学术

Systematic Review of Factors Associated with the Utilization of Radical Cystectomy for Bladder Cancer

Published:2019-03 Issue:2 Volume:2 Page:119-125
ISSN:2588-9311
Container-title:European Urology Oncology
language:en
Short-container-title:European Urology Oncology

Author:

Williams Stephen B.,Hudgins Hogan K.,Ray-Zack Mohamed D.,Chamie Karim,Smaldone Marc C.,Boorjian Stephen A.,Daneshmand Siamak,Black Peter C.,Kamat Ashish M.,Goebell Peter J.,Seiler Roland,Schmitz-Drager Bernd,Nawroth Roman,Baillargeon Jacques,Klaassen Zachary,Kulkarni Girish S.,Kim Simon P.,Lee Eugene K.,Holzbeierlein Jeffrey M.,Hollenbeck Brent K.,Gore John L.

Publisher

Elsevier BV

Subject

Urology,Radiology Nuclear Medicine and imaging,Oncology,Surgery

Reference23 articles.

1. Use of radical cystectomy for patients with invasive bladder cancer;Gore;J Natl Cancer Inst,2010

2. Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer;Williams;Cancer Causes Control,2017

3. Underutilization of radical cystectomy among patients diagnosed with clinical stage T2 muscle-invasive bladder cancer;Williams;Eur Urol Focus,2017

4. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology;Shabsigh;Eur Urol,2009

5. Contemporary use trends and survival outcomes in patients undergoing radical cystectomy or bladder-preservation therapy for muscle-invasive bladder cancer;Cahn;Cancer,2017

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status;International Journal of Molecular Sciences;2024-09-13

2. Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group;Journal of Clinical Oncology;2023-12-10

3. Sequential Intravesical Valrubicin and Docetaxel for the Salvage Treatment of Non–Muscle-Invasive Bladder Cancer;Journal of Urology;2022-11

4. Current State of Cell Therapies for Genitourinary Malignancies;The Cancer Journal;2022-07

5. Intracorporeal Urinary Diversion versus Extracorporeal Urinary Diversion during Robot-Assisted Radical Cystectomy;Hellenic Urology;2022-07